MARIA PAGAN: Open Payments
NPI 1134272628 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 77 payments from 13 companies in 2025. Trend: 2023 $117 · 2024 $1,551 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $296 |
| ABBVIE INC. | 15 | $159 |
| Phathom Pharmaceuticals, Inc. | 21 | $127 |
| Aimmune Therapeutics, Inc. | 4 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $107 |
| Janssen Biotech, Inc. | 5 | $103 |
| Novo Nordisk Inc | 2 | $90 |
| GENZYME CORPORATION | 3 | $68 |
| Lilly USA, LLC | 3 | $60 |
| Madrigal Pharmaceuticals | 1 | $32 |
Products named: VELSIPITY, XELJANZ, VOQUEZNA, ZENPEP, ENTYVIO, TREMFYA, RINVOQ, Wegovy.
Industry payments across FL — which companies pay providers there.
